Signaling pathways
-
BA2920 CustirsenSummary: Custirsen is a highly specific antisense oligonucleotide. - BA2921 A-192621Summary: A-192621 is a potent non-peptide, orally active, selective endothelin B receptor antagonist.
- BA2924 AK-778-XXMUSummary: AK-778-XXMU is a potent inhibitor of DNA binding 2 antagonists.
- BA2925 RX-3117Summary: RX-3117 (TV-1360) is a potent orally active anticancer and antimetabolite agent.
- BA2926 PDK4-IN-1Summary: PDK4-IN-1 is an anthraquinone derivative and a potent, orally active inhibitor of pyruvate dehydrogenase kinase 4.
- BA2927 MG-277Summary: MG-277 is a molecular gel degrader that efficiently induces degradation of translation termination factors based on E3 ligands.
- BA2928 STAT3-IN-3Summary: STAT3-IN-3 is a potent and selective inhibitor with antiproliferative activity.
- BA2929 Thalidomide-NH-CH2-COOHSummary: Thalidomide-NH-CH2-COOH is a Thalidomide-based, ligand that recruits CRBN proteins.
- BA2930 CearoinSummary: Enhances autophagy and induces apoptosis by promoting the production and activation of...
- BA2931 CipepofolSummary: Cipepofol (Ciprofol) is a novel 2,6-disubstituted phenol derivative that is a direct agonist and orthosteric modulator of receptors.